iRhythm Technologies, Inc. (NASDAQ:IRTC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 23, 2017, Casper de Clercq notified iRhythm Technologies, Inc. (the “Company”) of his decision not to stand for reelection to the Company’s Board of Directors (the “Board”) at the Company’s 2017 Annual Meeting of Stockholders (the “Annual Meeting”).  Mr. de Clercq will continue to serve as a member of the Board and its audit and compensation committees until the Annual Meeting.  Mr. de Clercq’s decision was based on personal reasons and was not due to a disagreement with the Company.

As a result of the decision of Casper de Clercq not to stand for re-election to the Board at the Annual Meeting, the Board, on April 26, 2017, resolved to move two of the directors from Class III (with a term expiring at the 2019 annual meeting of stockholders) to Class I (with a term expiring at the 2020 annual meeting of stockholders) to achieve a more equal balance of membership among the classes of directors. Accordingly, on April 26, 2017, each of Messrs. Kevin M. King and Raymond W. Scott agreed to resign as a Class III director and were immediately appointed to the Board as a Class I director. Mr. Scott continues to serve on the Company’s compensation and nominating and corporate governance committees. The resignation and reappointment of Messrs. King and Scott was effected solely to rebalance the Board classes, and for all other purposes, including vesting and other compensation matters, Messrs. King and Scott’s service on the Board is deemed to have continued uninterrupted.

About iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient’s physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.

iRhythm Technologies, Inc. (NASDAQ:IRTC) Recent Trading Information

iRhythm Technologies, Inc. (NASDAQ:IRTC) closed its last trading session up +0.63 at 35.24 with 611,950 shares trading hands.